Advertisement

New trends in neuropsychiatry: polyimmunotherapy—A new way of treatment in neurology and psychiatry. The 5S-7S Tilz protocol and the antigen clearing deficiency syndromes

  • G. P. Tilz
  • U. Demel
  • G. Wieselmann
  • H. Fabisch
  • H. G. Zapotoczky
  • H. Wachter
  • D. Fuchs
Conference paper
Part of the Key Topics in Brain Research book series (KEYTOPICS)

Abstract

In neurology and psychiatry similar immune mechanisms play a key role as in other diseases of the body. Cellular and humoral hypersensitivity and immunodeficiency occur and may become detrimental to central and peripheral neurology as well as in psychiatry. In immunodeficiency substitution or stimulation is indicated, whereas in hypersensitivity immunosuppression is the treatment of choice. All efficient forms of treatment cause some side effects, which under special conditions may become life threatening. In order to minimise these side effects we built up a new system of “Combination Therapy” of various immunomodulating drugs which we call in analogy to the polychemotherapy “Polyimmunotherapy”. This has been used for a decade of years with lower individual doses, less side effects and more therapeutical benefit.

Keywords

Mycophenolate Mofetil Polyclonal Activation Immune Complex Disease Anti Inflamma Auto Immunity 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Copyright information

© Springer-Verlag/Wien 1997

Authors and Affiliations

  • G. P. Tilz
    • 1
  • U. Demel
    • 1
  • G. Wieselmann
    • 2
  • H. Fabisch
    • 2
  • H. G. Zapotoczky
    • 2
  • H. Wachter
    • 3
  • D. Fuchs
    • 3
  1. 1.Clinical ImmunologyUniversity of GrazAustria
  2. 2.Clinic of NeuropsychiatryLKH GrazAustria
  3. 3.Department of BiochemistryUniversity of InnsbruckInnsbruckAustria

Personalised recommendations